Neurology

Please select here to E-mail us

Or here to request our free of charge DVD documentaries and Printed Versions of our Nutritional Medicine Research Newsletter

Please select here if you would like to receive research updates on a cancer related condition.

Or here, for research updates on Neurological Conditions like Shy-Drager, MSA and Parkinson’s disease.

GC100 is an organic preparation that contains molecular complexes of the most powerful anti-tumor substances found in nature. Select here to view our LIVE TV RESEARCH

Select a link below to go to any of the main pages of the Neurology Section of this web site:

1.-The Neurogenic Diet in the Treatment of Neuro-degenerative Disorders
Basic proposal for clinical studies concerning MSA and Parkinson’s Disease.

2.- Proposal for a Clinical Study to Test the Effectiveness of a Neurogenic  Approach in the Treatment of MSA and Parkinson’s Disease.

3.- View Recent Research Updates. Video Reports, Publications, Research Information.

4.- To View the Full Main Research Articles on the Discovery of Human Brain Neurogenesis

5.- THE HOME PAGE OF OUR WEB SITE

PARKINSON’S DISEASE VIDEO DOCUMENTARY
PERIOD  
1996 TO 2011

Select here or picture above to view the video on a Standard Windows Player

Select here to listen to Audio Voice Reports and Testimonials on RG-40 and Parkinson’s disease.

Or Select here to view recent research updates, videos and power point presentations.

Select here or the picture above to view the view with Flash Video Player

Once the player is on screen, select the green arrow on the bottom left to start playing the video.

MULTIPLE SYSTEM ATROPHY (MSA), SHY DRAGER SYNDROME VIDEO DOCUMENTARY
PERIOD  
1996 TO 2011

Select here or picture above to view the video on a Standard Windows Player

Select here or the picture above to view the video with Flash Video Player.

Once the player is on screen, select the green arrow on the bottom left to start playing the video.

Select below to view a Power Point Slide Show

1.- View our Slide Show with Update on Human Brain Neurogenesis Research Publications.

2.- View our Slide Show with Suggested Home Light Exercises.

3.- View our Slide Show on Cat Infections Inducing Neurological Damage

4.- Please select here to view slides showing graphically the process whereby viruses penetrates the DNA of human cells

The above Power Point Slides are examples of the subjects we share in our screen and discuss during our Sunday Webinars. (Web Meetings)
Our webinars allow you to view on your PC or laptop at the time of the webinar, our power point presentations, listen to our explanations, ask questions and talk to other participants from anywhere in the world.

PLEASE SELECT HERE TO VIEW HOW TO ENTER OUR WEBINRS.

THE USE OF TYPE RG-40 CONCENTRATED VEGETABLE EXTRACT WITH MSA AND PARKINSON’S DISEASE.

Select to view RG-40 Video with Windows Media Player

Select to view RG-40 Video with Flash Video Player

RG-40

.1. - RG-40 is an organic vegetable extract, rich in amino acids and plant kingdom biological factors, some of them, required for the synthesis of neuronal dopamine receptors.

2.- RG-40 natural components are organic substances extracted from fruit and vegetables, and are therefore, easily allowed to penetrate the blood brain barrier and gain access to the Basal Ganglia, where they interact with the the DNA of dopaminergic neurons.

3.- RG-40 biological factors are transported inside the dopaminergic neurons reaching the nucleus, where they interact with DNA.

4.- DNA in the cell nucleus is the command centre where orders to carry out the synthesis of receptor proteins are executed.

 Shown in this graph is the molecular neurobiology of dopamine receptor synthesis.
 The process begins in the cell nucleus, where RG-40 activates specific genes, which induce DNA to be transcribed into messenger RNA
.

5.- Messenger RNA then travels to the endoplasmic reticulum where ribosomes cause the messenger RNA to be translated into partially formed dopamine receptor proteins.

6.- The next step is for partially formed dopamine receptor proteins to be transformed into complete dopamine receptor molecules in the Golgi Apparatus.

7.- Completely formed dopamine receptor molecules are proteins. They are transported to the cell membrane where they interact with the neurotransmitter dopamine.

8.- As a result of the interaction between the neurotransmitter dopamine and dopamine receptor molecules, the ability of our muscular system to perform movements is regulated.

9.- Neuronal dopamine receptor deficiency causes motor disability problems, such as those observed in conditions like MSA-P and Parkinson’s Disease.  

This figure is a schematic diagram of a dopamine receptor showing that it is a protein arranged essentially as a long chain of amino acids.

10.- The chain of amino acids, forming the dopamine receptor, winds in and out of the cell several times. This creates three regions of the receptor. Firstly, the extracellular portions are those parts of the chain entirely outside the neuron; secondly, the intracellular portions are those segments of the chain entirely inside the neuron and thirdly, the transmembrane portions, which are the regions of the receptor which reside within the membrane of the neuron.

11.- Each and all of the amino acid and biological factors required for the synthesis of this and other dopamine receptor molecules, are present in the organic vegetable extract RG-40, which is now used by all the PD and MSA patients participating in our studies.

12.- Most drugs available today to treat Parkinson’s Disease attempt to increase the concentration of the neurotransmitter dopamine or its agonists in areas of the brain which are affected in Parkinson’s disease. However, the activity of these drugs is limited by the number of neuronal dopamine receptors available to interact with the neurotransmitter dopamine or its drug agonists.

13.- No matter how much a patient increases the dosage of dopamine precursors like Sinemet, or of any of the dopamine agonists drugs, if there are not enough neuronal dopamine receptors to interact with, these drugs will not produce any further response at all.

This picture shows a representation of two dopamine receptors (small blue triangles at the bottom of the graphic), interacting with dopamine molecules secreted by the neuron located on top of them.

This picture shows an enlarged graphic representation of one dopamine receptor  interacting with the molecule dopamine

THE USE OF TYPE RG-40 CONCENTRATED VEGETABLE EXTRACT WITH MSA AND PARKINSON’S DISEASE.

1. - During the first ten days, please try to establish the dosage required to produce the optimum effect.
It is advisable to start taking the RG-40 extract with breakfast in the morning.

On the first day, it is recommended to start with half a teaspoonful of the Type RG-40. (Approx. 3 grams). The second day you can increase it  to 3/4 of a teaspoonful or 5 grams and increase it each morning by two grams, until you find the ideal dosage. Ussualy this ideal dosage is between 10 and 20 grams.

During this initial period, while finding the ideal dose, RG-40 should be taken only once a day, in the morning hours. The rest of the day, all other PD medication, should be taken as usual.

During this initial trial, the patient must try to identify the ideal dosage of the Type RG-40 that is suitable for his/her condition. The dosage will depend on absorption, tissue transport and the stage of the disease.  When adjusting the dose, take the following into consideration:
Too much Type RG-40 will produce some nausea or some form of dyskinesias (these are the large involuntary movements caused by an overdose.) Nausea represents the natural response of the body to protect against a too high Dopaminergic activity.
With too small a dose, there will be almost no response. Here the dose should be increased the next morning. The first response to the Type RG-40 is an evident release of rigidity that generally occurs one hour after taking it.

2.- RG-40 produces a clear improvement in the patient’s ability to move, walk, speak and exercise. It controls but does not eliminate tremor. It improves balance, reduces constipation and increases hours of good sleep. The

3. - The jar of RG-40 in use should be kept in the refrigerator but the jars to be stored, must be kept in the freezer. Mixing a tablespoonful of warm water and a tsp of honey with the RG-40 extract might facilitate its absorption.

We would like to invite you to participate in our Sunday Webinars
To Know more about it, please select here.
..

Select here to view our LIVE WEB TV
With Video Documentaries showing
20 Years History of our Research
.

Select a link below to go to any of the main pages of the Neurology Section of this web site:

1.-The Neurogenic Diet in the Treatment of Neuro-degenerative Disorders
Basic proposal for clinical studies concerning MSA and Parkinson’s Disease.

2.- Proposal for a Clinical Study to Test the Effectiveness of a Neurogenic  Approach in the Treatment of MSA and Parkinson’s Disease.

3.- View Recent Research Updates. Video Reports, Publications, Research Information.

4.- To View the Full Main Research Articles on the Discovery of Human Brain Neurogenesis

5.- THE HOME PAGE OF OUR WEB SITE

Nutritional Medicine Research
26 Priestgate, Peterborough  PE1 1WG.  United Kingdom

Telephone: From the USA :  01144 7930 915 588
From all other countries:  0044 7930 915 588
From the UK: 07930 915 588
 


Please select here to view information about all our Web Sites
in English and in various other Languages
.